The US External Ventricular Drain market revenue is expected to demonstrate steady growth from USD 290 Million in 2020 to nearly USD 490 Million by 2035. Key drivers fueling this upward trend include the rising burden of neurological diseases, increased adoption of technologically advanced EVD systems, and improved reimbursement policies. The most significant acceleration is forecasted between 2025 and 2030, where annual investments in digital and smart EVDs are anticipated to drive market expansion. The growing awareness among clinicians and improved clinical protocols for brain injuries also contribute to sustained revenue growth during the forecast period.
Read More - https://bussinessinsights.com/research-report/us-external-ventricular-drain
Hydrocephalus is projected to account for the largest share at 42% of EVD applications in 2025, driven by its high treatment prevalence. Traumatic brain injury follows at 25%, supported by increased emergency neurosurgical procedures. Intracerebral hemorrhage and subarachnoid hemorrhage collectively represent 21% of applications as the use of EVDs expands in critical care. Meningitis and other applications account for 12%, reflecting growing awareness of EVD use in complex neurological infections. The dominance of hydrocephalus stems from its chronic management needs, but robust growth is anticipated among trauma and cerebrovascular indications.
Request Free Sample- https://bussinessinsights.com/request/medical-devices/us-external-ventricular-drain
Who are the key players in US External Ventricular Drain industry?
The top 5 players in the US External Ventricular Drain industry include Medtronic, Integra LifeSciences, B. Braun Melsungen AG, Spiegelberg, and Sophysa. These companies dominate the market with advanced technologies, strong market presence, significant R&D investment, and diversified product offerings catering to neurosurgical and critical care needs.
What is the US External Ventricular Drain growth?
The US External Ventricular Drain market is experiencing steady growth, driven by rising incidences of traumatic brain injury and neurological disorders. For example, Medtronic reported increased demand for its neurocritical care products in 2023, boosting market expansion and supporting improved patient management in acute healthcare settings.
Which segment accounted for the largest US External Ventricular Drain share?
Among applications, the traumatic brain injury segment accounted for the largest share of the US External Ventricular Drain market. This dominance is attributed to the high incidence of head injuries requiring cerebrospinal fluid management and the critical role of EVDs in treating increased intracranial pressure in emergency cases.
Thanks & Regards,
Manisha C
sales [at] bussinessinsights.com